PERSISTENT HPV16 INFECTION

Clinical trials for PERSISTENT HPV16 INFECTION explained in plain language.

Never miss a new study

Get alerted when new PERSISTENT HPV16 INFECTION trials appear

Sign up with your email to follow new studies for PERSISTENT HPV16 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New shot aims to clear stubborn HPV infection in women

Disease control Not yet recruiting

This early-stage study tests a new drug called NWRD09 in 78 women aged 18-60 who have had a persistent HPV16 infection for at least 6 months. The goal is to see if the injection is safe and can help the body clear the virus. Participants will receive either the drug or a placebo,…

Matched conditions: PERSISTENT HPV16 INFECTION

Phase: PHASE1, PHASE2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

PERSISTENT HPV16 INFECTION

Get alerted when new PERSISTENT HPV16 INFECTION trials appear

New shot aims to clear stubborn HPV infection in women